SLXN

Silexion Therapeutics
SLXN

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $613K invested in Silexion Therapeutics in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$536K
2
+$47K
3
+$14K
4
TSS
Two Sigma Securities
New York
+$7.94K
5
UBS Group
UBS Group
Switzerland
+$7.91K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$536K
2
$47K
3
$14K
4
$7.94K
5
$7.91K